Shore Point Advisors, LLC Sigilon Therapeutics, Inc. Transaction History

Shore Point Advisors, LLC

  • $181 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 26, 2022
SELL
$1.24 - $3.03 $24 - $60
-20 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$2.58 - $6.13 $51 - $122
20 New
20 $0

About Sigilon Therapeutics, Inc.

SGTX Quotes by TradingView
  • Ticker SGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,399,300
  • Description
  • Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neuro...
More about SGTX
Track This Portfolio

Track Shore Point Advisors, LLC Portfolio

Follow Shore Point Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shore Point Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shore Point Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email